Ad is loading...
PGEN
Price
$0.82
Change
-$0.06 (-6.82%)
Updated
Nov 15 closing price
101 days until earnings call
RPTX
Price
$3.11
Change
-$0.14 (-4.31%)
Updated
Nov 15 closing price
107 days until earnings call
Ad is loading...

PGEN vs RPTX

Header iconPGEN vs RPTX Comparison
Open Charts PGEN vs RPTXBanner chart's image
Precigen
Price$0.82
Change-$0.06 (-6.82%)
Volume$1.78M
CapitalizationN/A
Repare Therapeutics
Price$3.11
Change-$0.14 (-4.31%)
Volume$234.6K
CapitalizationN/A
PGEN vs RPTX Comparison Chart
Loading...
PGEN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RPTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
PGEN vs. RPTX commentary
Nov 18, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PGEN is a StrongSell and RPTX is a Sell.

COMPARISON
Comparison
Nov 18, 2024
Stock price -- (PGEN: $0.82 vs. RPTX: $3.11)
Brand notoriety: PGEN and RPTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PGEN: 236% vs. RPTX: 221%
Market capitalization -- PGEN: $240M vs. RPTX: $132.21M
PGEN [@Biotechnology] is valued at $240M. RPTX’s [@Biotechnology] market capitalization is $132.21M. The market cap for tickers in the [@Biotechnology] industry ranges from $472.8B to $0. The average market capitalization across the [@Biotechnology] industry is $2.66B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PGEN’s FA Score shows that 0 FA rating(s) are green whileRPTX’s FA Score has 0 green FA rating(s).

  • PGEN’s FA Score: 0 green, 5 red.
  • RPTX’s FA Score: 0 green, 5 red.
According to our system of comparison, RPTX is a better buy in the long-term than PGEN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PGEN’s TA Score shows that 4 TA indicator(s) are bullish while RPTX’s TA Score has 3 bullish TA indicator(s).

  • PGEN’s TA Score: 4 bullish, 5 bearish.
  • RPTX’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, PGEN is a better buy in the short-term than RPTX.

Price Growth

PGEN (@Biotechnology) experienced а -15.96% price change this week, while RPTX (@Biotechnology) price change was -13.37% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -8.58%. For the same industry, the average monthly price growth was -5.90%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

PGEN is expected to report earnings on Feb 26, 2025.

RPTX is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Biotechnology (-8.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PGEN($240M) has a higher market cap than RPTX($132M). PGEN YTD gains are higher at: -38.799 vs. RPTX (-57.397). RPTX has higher annual earnings (EBITDA): -93.8M vs. PGEN (-130.97M). RPTX has more cash in the bank: 208M vs. PGEN (19.5M). RPTX has less debt than PGEN: RPTX (2.18M) vs PGEN (6.34M). RPTX has higher revenues than PGEN: RPTX (68.7M) vs PGEN (4.39M).
PGENRPTXPGEN / RPTX
Capitalization240M132M182%
EBITDA-130.97M-93.8M140%
Gain YTD-38.799-57.39768%
P/E RatioN/AN/A-
Revenue4.39M68.7M6%
Total Cash19.5M208M9%
Total Debt6.34M2.18M292%
FUNDAMENTALS RATINGS
PGEN: Fundamental Ratings
PGEN
OUTLOOK RATING
1..100
17
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
85
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PGENRPTX
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
N/A
Stochastic
ODDS (%)
Bearish Trend 3 days ago
86%
Bullish Trend 3 days ago
84%
Momentum
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
84%
MACD
ODDS (%)
Bullish Trend 3 days ago
82%
Bearish Trend 3 days ago
89%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
89%
Advances
ODDS (%)
Bullish Trend 7 days ago
83%
Bullish Trend 7 days ago
82%
Declines
ODDS (%)
Bearish Trend 3 days ago
86%
Bearish Trend 3 days ago
88%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
90%
Bearish Trend 3 days ago
85%
Aroon
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
85%
View a ticker or compare two or three
Ad is loading...
PGEN
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RPTX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VXTRF0.06N/A
+3.88%
VOXTUR ANALYTICS CORP.
TOTTX12.03-0.07
-0.58%
Transamerica Mid Cap Value Opps I3
GLRBX22.77-0.16
-0.70%
James Balanced: Golden Rainbow R
TSLIX6.73-0.07
-1.03%
Transamerica Small Cap Value I
LAMQX24.52-0.27
-1.09%
Lord Abbett Dividend Growth R2

RPTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RPTX has been loosely correlated with HRTX. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if RPTX jumps, then HRTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RPTX
1D Price
Change %
RPTX100%
-4.31%
HRTX - RPTX
44%
Loosely correlated
-4.03%
PGEN - RPTX
43%
Loosely correlated
-7.11%
ARCT - RPTX
40%
Loosely correlated
-12.65%
VIR - RPTX
40%
Loosely correlated
-7.29%
ADPT - RPTX
39%
Loosely correlated
-8.96%
More